| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma
|
Park, Steven I.
|
|
|
|
11 |
p. 2548-2555
|
artikel
|
| 2 |
Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia
|
Wallace, Danielle S.
|
|
|
|
11 |
p. 2496-2503
|
artikel
|
| 3 |
A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion
|
Miller, Christopher A.
|
|
|
|
11 |
p. 1295-1299
|
artikel
|
| 4 |
A complex proinflammatory cascade mediates the activation of HSCs upon LPS exposure in vivo
|
Demel, Uta Margareta
|
|
|
|
11 |
p. 3513-3528
|
artikel
|
| 5 |
A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation
|
Wang, Chen
|
|
|
|
11 |
p. 2590-2605
|
artikel
|
| 6 |
A cross-sectional analysis of cardiovascular disease in the hemophilia population
|
Sood, Suman L.
|
|
|
|
11 |
p. 1325-1333
|
artikel
|
| 7 |
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD
|
Hirai, Toshihito
|
|
|
|
11 |
p. 2528-2538
|
artikel
|
| 8 |
Activation of the vitamin D receptor transcription factor stimulates the growth of definitive erythroid progenitors
|
Barminko, Jeffrey
|
|
|
|
11 |
p. 1207-1219
|
artikel
|
| 9 |
Adoptive T-cell therapy for pediatric cytomegalovirus-associated retinitis
|
Seo, Shiney
|
|
|
|
11 |
p. 1774-1777
|
artikel
|
| 10 |
A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant
|
French, Shauna L.
|
|
|
|
11 |
p. 1283-1293
|
artikel
|
| 11 |
Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia
|
Ferguson, Daniel C.
|
|
|
|
11 |
p. 3386-3397
|
artikel
|
| 12 |
Anakinra utilization in refractory pediatric CAR T-cell associated toxicities
|
Diorio, Caroline
|
|
|
|
11 |
p. 3398-3403
|
artikel
|
| 13 |
Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis
|
Weyand, Angela C.
|
|
|
|
11 |
p. 1670-1680
|
artikel
|
| 14 |
A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas
|
Munshi, Manit
|
|
|
|
11 |
p. 3332-3338
|
artikel
|
| 15 |
A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale
|
Gordon, Max J.
|
|
|
|
11 |
p. 2632-2642
|
artikel
|
| 16 |
A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia
|
Lee, Christine S.M.
|
|
|
|
11 |
p. 3494-3506
|
artikel
|
| 17 |
A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy
|
Hirayama, Alexandre V.
|
|
|
|
11 |
p. 2479-2493
|
artikel
|
| 18 |
Antifibrinolytic therapy for preventing VWD-related postpartum hemorrhage: indications and limitations
|
Kouides, Peter A.
|
|
|
|
11 |
p. 699-702
|
artikel
|
| 19 |
Apolipoprotein A-I enhances activated protein C cytoprotective activity
|
Gleeson, Eimear M.
|
|
|
|
11 |
p. 2404-2408
|
artikel
|
| 20 |
A potent tetravalent T-cell–engaging bispecific antibody against CD33 in acute myeloid leukemia
|
Hoseini, Sayed Shahabuddin
|
|
|
|
11 |
p. 1250-1258
|
artikel
|
| 21 |
A predictive model for bone marrow disease in cytopenia based on noninvasive procedures
|
Træden, Dicte
|
|
|
|
11 |
p. 3541-3550
|
artikel
|
| 22 |
ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV
|
Strati, Paolo
|
|
|
|
11 |
p. 2586-2589
|
artikel
|
| 23 |
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia
|
Irani, Yazad D.
|
|
|
|
11 |
p. 2364-2374
|
artikel
|
| 24 |
Associations of α-thalassemia and BCL11A with stroke in Nigerian, United States, and United Kingdom sickle cell anemia cohorts
|
Saraf, Santosh L.
|
|
|
|
11 |
p. 693-698
|
artikel
|
| 25 |
Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting
|
Ayuk, Francis A.
|
|
|
|
11 |
p. 2523-2527
|
artikel
|
| 26 |
Ay C, Pabinger I, Kovacevic KD, et al. The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease. Blood Adv. 2022;6(18):5467-5476.
|
|
|
|
|
11 |
p. 2656
|
artikel
|
| 27 |
Balancing considerations and qualifying conclusions for cost-effectiveness of therapies for relapsed/refractory follicular lymphoma
|
Potnis, Kunal C.
|
|
|
|
11 |
p. 2573-2574
|
artikel
|
| 28 |
Basal type I interferon signaling has only modest effects on neonatal and juvenile hematopoiesis
|
Li, Yanan
|
|
|
|
11 |
p. 2609-2621
|
artikel
|
| 29 |
BCL-XL antagonism selectively reduces neutrophil life span within inflamed tissues without causing neutropenia
|
Carrington, Emma M.
|
|
|
|
11 |
p. 2550-2562
|
artikel
|
| 30 |
Blocking human protein C anticoagulant activity improves clotting defects of hemophilia mice expressing human protein C
|
Jiang, Miao
|
|
|
|
11 |
p. 3304-3314
|
artikel
|
| 31 |
Blood volume–based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease
|
Ragni, Margaret V.
|
|
|
|
11 |
p. 703-706
|
artikel
|
| 32 |
Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers
|
Paczesny, Sophie
|
|
|
|
11 |
p. 2519-2522
|
artikel
|
| 33 |
BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient
|
Nakasone, Hideki
|
|
|
|
11 |
p. 1750-1760
|
artikel
|
| 34 |
Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma
|
Iyer, Aishwarya
|
|
|
|
11 |
p. 2489-2500
|
artikel
|
| 35 |
CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
|
Giustiniani, Jérôme
|
|
|
|
11 |
p. 3507-3512
|
artikel
|
| 36 |
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany
|
Bader, Peter
|
|
|
|
11 |
p. 2436-2448
|
artikel
|
| 37 |
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma
|
Okamoto, Akinao
|
|
|
|
11 |
p. 3230-3233
|
artikel
|
| 38 |
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation
|
Iland, Harry J.
|
|
|
|
11 |
p. 2580-2585
|
artikel
|
| 39 |
Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping
|
Jean, Jeffrey
|
|
|
|
11 |
p. 3343-3346
|
artikel
|
| 40 |
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma
|
Cook, Joselle
|
|
|
|
11 |
p. 3268-3279
|
artikel
|
| 41 |
Clinical and epidemiological features of paroxysmal cold hemoglobinuria: a systematic review
|
Jacobs, Jeremy W.
|
|
|
|
11 |
p. 2520-2527
|
artikel
|
| 42 |
Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination
|
Lee, Agnes Y.Y.
|
|
|
|
11 |
p. 3315-3320
|
artikel
|
| 43 |
Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia
|
Kubasch, Anne Sophie
|
|
|
|
11 |
p. 1187-1190
|
artikel
|
| 44 |
Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry)
|
Mirza, Reza
|
|
|
|
11 |
p. 2460-2467
|
artikel
|
| 45 |
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine
|
Harris, Andrew C.
|
|
|
|
11 |
p. 1198-1206
|
artikel
|
| 46 |
Comparison of the effectiveness and safety of direct oral anticoagulants: a nationwide propensity score–weighted study
|
Ingason, Arnar B.
|
|
|
|
11 |
p. 2564-2572
|
artikel
|
| 47 |
Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19
|
Henderson, Michael W.
|
|
|
|
11 |
p. 3367-3377
|
artikel
|
| 48 |
Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT
|
Fitzhugh, Courtney D.
|
|
|
|
11 |
p. 652-661
|
artikel
|
| 49 |
Dasatinib-induced spleen contraction leads to transient lymphocytosis
|
Marcos-Jiménez, Ana
|
|
|
|
11 |
p. 2418-2430
|
artikel
|
| 50 |
Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML
|
Stasik, Sebastian
|
|
|
|
11 |
p. 3294-3303
|
artikel
|
| 51 |
Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes
|
Stomper, Julia
|
|
|
|
11 |
p. 3551-3555
|
artikel
|
| 52 |
Diagnosis of deep vein thrombosis of the upper extremity: a systematic review and meta-analysis of test accuracy
|
Patel, Payal
|
|
|
|
11 |
p. 2516-2522
|
artikel
|
| 53 |
Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation
|
Inamoto, Yoshihiro
|
|
|
|
11 |
p. 2409-2417
|
artikel
|
| 54 |
Differential antibacterial control by neutrophil subsets
|
Leliefeld, Pieter H.C.
|
|
|
|
11 |
p. 1344-1355
|
artikel
|
| 55 |
Discovery and characterization of 2 novel subpopulations of aPS/PT antibodies in patients at high risk of thrombosis
|
Chinnaraj, Mathivanan
|
|
|
|
11 |
p. 1738-1749
|
artikel
|
| 56 |
Dissecting platelet proteomics to understand the pathophysiology of immune thrombocytopenia: studies in mouse models
|
Martínez-Botía, Patricia
|
|
|
|
11 |
p. 3529-3534
|
artikel
|
| 57 |
Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients
|
Alshalani, Abdulrahman
|
|
|
|
11 |
p. 3260-3267
|
artikel
|
| 58 |
Editorial Board
|
|
|
|
|
11 |
p. i
|
artikel
|
| 59 |
Editorial Board
|
|
|
|
|
11 |
p. i
|
artikel
|
| 60 |
Editorial Board
|
|
|
|
|
11 |
p. i
|
artikel
|
| 61 |
Editorial Board
|
|
|
|
|
11 |
p. i
|
artikel
|
| 62 |
Editorial Board
|
|
|
|
|
11 |
p. i
|
artikel
|
| 63 |
Editorial Board
|
|
|
|
|
11 |
p. i
|
artikel
|
| 64 |
Editorial Board
|
|
|
|
|
11 |
p. i
|
artikel
|
| 65 |
Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia
|
Epstein-Peterson, Zachary D.
|
|
|
|
11 |
p. 3433-3439
|
artikel
|
| 66 |
Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AML
|
Narayanan, Damodaran
|
|
|
|
11 |
p. 2539-2549
|
artikel
|
| 67 |
Emicizumab use in major orthopedic surgery
|
Seaman, Craig D.
|
|
|
|
11 |
p. 1722-1724
|
artikel
|
| 68 |
Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG mice
|
Lysenko, Veronika
|
|
|
|
11 |
p. 2477-2488
|
artikel
|
| 69 |
Enhanced hepatic clearance of hyposialylated platelets explains thrombocytopenia in GNE-related macrothrombocytopenia
|
Noordermeer, Tessa
|
|
|
|
11 |
p. 3347-3351
|
artikel
|
| 70 |
Enhanced labile plasma iron in hematopoietic stem cell transplanted patients promotes Aspergillus outgrowth
|
Petzer, Verena
|
|
|
|
11 |
p. 1695-1700
|
artikel
|
| 71 |
Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells
|
Pan, Feng
|
|
|
|
11 |
p. 2504-2519
|
artikel
|
| 72 |
Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma
|
Welch, Jennifer J.G.
|
|
|
|
11 |
p. 681-684
|
artikel
|
| 73 |
Evaluating measurable residual disease in acute myeloid leukemia
|
Ravandi, Farhad
|
|
|
|
11 |
p. 1356-1366
|
artikel
|
| 74 |
Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)
|
Yin, Jun
|
|
|
|
11 |
p. 1714-1721
|
artikel
|
| 75 |
Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology Group
|
Matloub, Yousif
|
|
|
|
11 |
p. 1647-1656
|
artikel
|
| 76 |
Extracellular vesicle proteomic analysis leads to the discovery of HDGF as a new factor in multiple myeloma biology
|
Hoelzinger, Dominique B.
|
|
|
|
11 |
p. 3458-3471
|
artikel
|
| 77 |
Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis
|
Gooptu, Mahasweta
|
|
|
|
11 |
p. 2309-2316
|
artikel
|
| 78 |
Front Matter
|
|
|
|
|
11 |
p. ii
|
artikel
|
| 79 |
G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL
|
Iacobucci, Ilaria
|
|
|
|
11 |
p. 3255-3259
|
artikel
|
| 80 |
Gene expression profiling of gray zone lymphoma
|
Sarkozy, Clémentine
|
|
|
|
11 |
p. 2523-2535
|
artikel
|
| 81 |
Genetic variants of PKLR are associated with acute pain in sickle cell disease
|
Wang, Xunde
|
|
|
|
11 |
p. 3535-3540
|
artikel
|
| 82 |
Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia
|
Yamato, Genki
|
|
|
|
11 |
p. 3207-3219
|
artikel
|
| 83 |
Genomics of PDGFR-rearranged hypereosinophilic syndrome
|
Rheinbay, Esther
|
|
|
|
11 |
p. 2558-2563
|
artikel
|
| 84 |
Gupta V, Kennedy JA, Capo-Chichi J-M, et al. Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL–negative MPN in blast phase. Blood Adv. 2020;4(21):5562-5573.
|
|
|
|
|
11 |
p. 2518
|
artikel
|
| 85 |
Gupta V, Kim S, Hu Z-H, et al. Comparison of outcomes of HCT in blast phase of BCR-ABL1 − MPN with de novo AML and with AML following MDS. Blood Adv. 2020;4(19):4748–4757.
|
|
|
|
|
11 |
p. 2515
|
artikel
|
| 86 |
Hard-wired biases in trials: maintenance azacitidine in patients with acute myeloid leukemia and framework for future trials
|
Olivier, Timothée
|
|
|
|
11 |
p. 3329-3331
|
artikel
|
| 87 |
High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes
|
Wang, Yu-Hung
|
|
|
|
11 |
p. 2528-2533
|
artikel
|
| 88 |
High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential
|
Busque, Lambert
|
|
|
|
11 |
p. 2430-2438
|
artikel
|
| 89 |
Human peripheral blood DNAM-1neg NK cells are a terminally differentiated subset with limited effector functions
|
Stannard, Kimberley A.
|
|
|
|
11 |
p. 1681-1694
|
artikel
|
| 90 |
Identification of novel γ-globin inducers among all potential erythroid druggable targets
|
Yu, Lei
|
|
|
|
11 |
p. 3280-3285
|
artikel
|
| 91 |
Identification of patients with hemoglobin SS/Sβ0 thalassemia disease and pain crises within electronic health records
|
Singh, Ashima
|
|
|
|
11 |
p. 1172-1179
|
artikel
|
| 92 |
Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming
|
Chinnadurai, Raghavan
|
|
|
|
11 |
p. 628-643
|
artikel
|
| 93 |
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma
|
Epperla, Narendranath
|
|
|
|
11 |
p. 2287-2296
|
artikel
|
| 94 |
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
|
van Doesum, Jaap A.
|
|
|
|
11 |
p. 2645-2655
|
artikel
|
| 95 |
Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient
|
Oza, Aabha
|
|
|
|
11 |
p. 2387-2391
|
artikel
|
| 96 |
In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1 + BCP-ALL
|
Fiedler, Eleanor R.C.
|
|
|
|
11 |
p. 1229-1242
|
artikel
|
| 97 |
Keleku-Lukwete N, Suzuki M, Panda H, et al. Nrf2 activation in myeloid cells and endothelial cells differentially mitigates sickle cell disease pathology in mice. Blood Adv. 2019;3(8):1285-1297.
|
|
|
|
|
11 |
p. 1701
|
artikel
|
| 98 |
KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A/LRF in erythroid cells
|
Norton, Laura J.
|
|
|
|
11 |
p. 685-692
|
artikel
|
| 99 |
Kruppel-like factor 4 regulates neutrophil activation
|
Shen, Yuyan
|
|
|
|
11 |
p. 662-668
|
artikel
|
| 100 |
Kumar AJ, Kim S, Hemmer MT, et al. Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants. Blood Adv. 2018;2(9):1022-1031.
|
|
|
|
|
11 |
p. 1294
|
artikel
|
| 101 |
Lai C, Ranpura V, Wu C, et al. Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab. Blood Adv. 2019;3(7):980-983.
|
|
|
|
|
11 |
p. 1657
|
artikel
|
| 102 |
Lasting shift in the gut microbiota in patients with acute myeloid leukemia
|
Rashidi, Armin
|
|
|
|
11 |
p. 3451-3457
|
artikel
|
| 103 |
Left ventricular diastolic function as a possible predictor of severe carfilzomib-induced cardiovascular events
|
Abe, Yoshiaki
|
|
|
|
11 |
p. 1725-1728
|
artikel
|
| 104 |
Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis
|
Carobbio, Alessandra
|
|
|
|
11 |
p. 1729-1737
|
artikel
|
| 105 |
Lineage tracing of murine adult hematopoietic stem cells reveals active contribution to steady-state hematopoiesis
|
Chapple, Richard H.
|
|
|
|
11 |
p. 1220-1228
|
artikel
|
| 106 |
Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring
|
Qi, Fei
|
|
|
|
11 |
p. 2505-2514
|
artikel
|
| 107 |
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
|
Shapiro, Amy D.
|
|
|
|
11 |
p. 3422-3432
|
artikel
|
| 108 |
Long-term remissions after stopping pembrolizumab for relapsed or refractory multiple myeloma
|
Badros, Ashraf Z.
|
|
|
|
11 |
p. 1658-1660
|
artikel
|
| 109 |
Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells
|
Maurer, Katie
|
|
|
|
11 |
p. 2431-2435
|
artikel
|
| 110 |
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies
|
Chang, Andres
|
|
|
|
11 |
p. 2459-2462
|
artikel
|
| 111 |
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma
|
Puig, Noemí
|
|
|
|
11 |
p. 3234-3239
|
artikel
|
| 112 |
Megakaryocyte/platelet-derived TGF-β1 inhibits megakaryopoiesis in bone marrow by regulating thrombopoietin production in liver
|
Gostynska, Sandra
|
|
|
|
11 |
p. 3321-3328
|
artikel
|
| 113 |
Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis
|
Flora, Gagan D.
|
|
|
|
11 |
p. 2347-2359
|
artikel
|
| 114 |
Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo
|
Thamilarasan, Madhan
|
|
|
|
11 |
p. 2372-2386
|
artikel
|
| 115 |
Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma
|
Ottolini, Barbara
|
|
|
|
11 |
p. 2392-2403
|
artikel
|
| 116 |
Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing
|
Niazi, Hira
|
|
|
|
11 |
p. 1702-1713
|
artikel
|
| 117 |
Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma
|
Gribben, John
|
|
|
|
11 |
p. 2494-2495
|
artikel
|
| 118 |
Neutrophils acquire antigen-presenting cell features after phagocytosis of IgG-opsonized erythrocytes
|
Meinderts, Sanne M.
|
|
|
|
11 |
p. 1761-1773
|
artikel
|
| 119 |
New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT
|
Elfeky, Reem
|
|
|
|
11 |
p. 2418-2429
|
artikel
|
| 120 |
Novel mouse model resistant to irreversible BTK inhibitors: a tool identifying new therapeutic targets and side effects
|
Estupiñán, H. Yesid
|
|
|
|
11 |
p. 2439-2450
|
artikel
|
| 121 |
On a collision course: SARS-CoV-2 variants and CAR T cells
|
Auletta, Jeffery J.
|
|
|
|
11 |
p. 2643-2644
|
artikel
|
| 122 |
Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells
|
Jin, Xi
|
|
|
|
11 |
p. 1259-1271
|
artikel
|
| 123 |
Outcomes associated with apixaban vs warfarin in patients with renal dysfunction
|
Hanni, Claudia
|
|
|
|
11 |
p. 2366-2371
|
artikel
|
| 124 |
Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria
|
Wong, Raymond Siu Ming
|
|
|
|
11 |
p. 2468-2478
|
artikel
|
| 125 |
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates
|
Saliba, Antoine N.
|
|
|
|
11 |
p. 2360-2363
|
artikel
|
| 126 |
pH-dependent conformation of multimeric von Willebrand factor
|
Smith, Ian W.
|
|
|
|
11 |
p. 2554-2557
|
artikel
|
| 127 |
Plasma hepcidin is associated with future risk of venous thromboembolism
|
Ellingsen, Trygve S.
|
|
|
|
11 |
p. 1191-1197
|
artikel
|
| 128 |
Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
|
Lynch, Ryan C.
|
|
|
|
11 |
p. 2449-2458
|
artikel
|
| 129 |
Positron emission tomography–computed tomography predictors of progression after DA-R-EPOCH for PMBCL
|
Pinnix, Chelsea C.
|
|
|
|
11 |
p. 1334-1343
|
artikel
|
| 130 |
Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation
|
Epperla, Narendranath
|
|
|
|
11 |
p. 1661-1669
|
artikel
|
| 131 |
Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial
|
Broers, Annoek E.C.
|
|
|
|
11 |
p. 3378-3385
|
artikel
|
| 132 |
Prediction of outcomes after second-line treatment for acute graft-versus-host disease
|
Vo, Phuong
|
|
|
|
11 |
p. 3220-3229
|
artikel
|
| 133 |
Proteomic identification of proliferation and progression markers in human polycythemia vera stem and progenitor cells
|
Tan, Ge
|
|
|
|
11 |
p. 3480-3493
|
artikel
|
| 134 |
Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin
|
Kremers, Romy M.W.
|
|
|
|
11 |
p. 1315-1324
|
artikel
|
| 135 |
Racial and socioeconomic disparities in CLL/SLL: analysis of SEER data from 2006 to 2019
|
Kittai, Adam S.
|
|
|
|
11 |
p. 2575-2579
|
artikel
|
| 136 |
Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?
|
Robinson, Tara M.
|
|
|
|
11 |
p. 1180-1186
|
artikel
|
| 137 |
Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort
|
Schoettler, Michelle
|
|
|
|
11 |
p. 2536-2547
|
artikel
|
| 138 |
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results
|
Jaeger, Ulrich
|
|
|
|
11 |
p. 2283-2286
|
artikel
|
| 139 |
Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis
|
Fronas, Synne G.
|
|
|
|
11 |
p. 2468-2476
|
artikel
|
| 140 |
Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation
|
Cheng, Matthew P.
|
|
|
|
11 |
p. 1272-1276
|
artikel
|
| 141 |
Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapy
|
Furqan, Fateeha
|
|
|
|
11 |
p. 2463-2467
|
artikel
|
| 142 |
SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia
|
Marrero, Richard J.
|
|
|
|
11 |
p. 2538-2550
|
artikel
|
| 143 |
SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa
|
Childers, Kenneth C.
|
|
|
|
11 |
p. 3240-3254
|
artikel
|
| 144 |
Serologic characterization of anti-protamine/heparin and anti-PF4/heparin antibodies
|
Lee, Grace M.
|
|
|
|
11 |
p. 644-651
|
artikel
|
| 145 |
Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis
|
Sharma, Parth
|
|
|
|
11 |
p. 2534-2537
|
artikel
|
| 146 |
SGK1 inhibition induces fetal hemoglobin expression and delays polymerization in sickle erythroid cells
|
Hara, Yannis
|
|
|
|
11 |
p. 2317-2323
|
artikel
|
| 147 |
Shared and distinct genetic features in human and canine B-cell lymphomas
|
Coyle, Krysta Mila
|
|
|
|
11 |
p. 3404-3409
|
artikel
|
| 148 |
Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita
|
Khincha, Payal P.
|
|
|
|
11 |
p. 1243-1249
|
artikel
|
| 149 |
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
|
Marques-Piubelli, Mario L.
|
|
|
|
11 |
p. 3286-3293
|
artikel
|
| 150 |
Structural connectivity mediates the relationship between blood oxygenation and cognitive function in sickle cell anemia
|
Clayden, Jonathan D.
|
|
|
|
11 |
p. 2297-2308
|
artikel
|
| 151 |
Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
|
Di, Mengyang
|
|
|
|
11 |
p. 3339-3342
|
artikel
|
| 152 |
Sézary syndrome patient–derived models allow drug selection for personalized therapy
|
Gallardo, Fernando
|
|
|
|
11 |
p. 3410-3421
|
artikel
|
| 153 |
Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome
|
DiNardo, Courtney D.
|
|
|
|
11 |
p. 2378-2387
|
artikel
|
| 154 |
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
|
Daly, John
|
|
|
|
11 |
p. 3352-3366
|
artikel
|
| 155 |
The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice
|
Bochenek, Magdalena L.
|
|
|
|
11 |
p. 1300-1314
|
artikel
|
| 156 |
The great platelet paradox: evolution of platelet contribution to hemostasis, inflammation, and thrombosis after injury
|
Neal, Matthew D.
|
|
|
|
11 |
p. 2556
|
artikel
|
| 157 |
The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis
|
Lorentino, Francesca
|
|
|
|
11 |
p. 669-680
|
artikel
|
| 158 |
The role of aurora A and polo-like kinases in high-risk lymphomas
|
Murga-Zamalloa, Carlos
|
|
|
|
11 |
p. 1778-1787
|
artikel
|
| 159 |
The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?
|
Gamal, Wael
|
|
|
|
11 |
p. 2401-2417
|
artikel
|
| 160 |
Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation
|
Parunov, Leonid A.
|
|
|
|
11 |
p. 2622-2631
|
artikel
|
| 161 |
Tissue factor pathway inhibitor and bleeding tendency: can hormonal state explain the differences?
|
Dahm, Anders Erik Astrup
|
|
|
|
11 |
p. 2516-2517
|
artikel
|
| 162 |
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
|
Schimmer, Roman R.
|
|
|
|
11 |
p. 3201-3206
|
artikel
|
| 163 |
Transfusion therapy for sickle cell disease: what’s new?
|
Chou, Stella T.
|
|
|
|
11 |
p. 2551-2553
|
artikel
|
| 164 |
Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease
|
Boucault, Laetitia
|
|
|
|
11 |
p. 2501-2515
|
artikel
|
| 165 |
Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer
|
Kroone, Chantal
|
|
|
|
11 |
p. 2388-2400
|
artikel
|
| 166 |
Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19
|
Weiss, Lukas J.
|
|
|
|
11 |
p. 2324-2338
|
artikel
|
| 167 |
Under-representation of classical hematology training on hematology-oncology fellowship program websites in the United States
|
Panwar, Puja
|
|
|
|
11 |
p. 2375-2377
|
artikel
|
| 168 |
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting
|
Klein, Lauren J.
|
|
|
|
11 |
p. 2339-2346
|
artikel
|
| 169 |
Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia
|
Barr, Paul M.
|
|
|
|
11 |
p. 3440-3450
|
artikel
|
| 170 |
Use of multiple urinary biomarkers for the early detection of chronic kidney disease in sickle cell anemia
|
Castro-Sesquen, Yagahira E.
|
|
|
|
11 |
p. 2606-2608
|
artikel
|
| 171 |
Utilization of initial chemotherapy for newly diagnosed acute myeloid leukemia in the United States
|
Bhatt, Vijaya Raj
|
|
|
|
11 |
p. 1277-1282
|
artikel
|
| 172 |
Validation and clinical application of transactivation assays for RUNX1 variant classification
|
Decker, Melanie
|
|
|
|
11 |
p. 3195-3200
|
artikel
|
| 173 |
Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study
|
Warren, Beth Boulden
|
|
|
|
11 |
p. 2451-2459
|
artikel
|
| 174 |
Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
|
Phillips, Tycel
|
|
|
|
11 |
p. 3472-3479
|
artikel
|
Tijdschrift beschrijving